Jazz Pharmaceuticals plc (JAZZ) has a consensus analyst rating of Buy, based on 47 analysts covering the stock. Of those, 41 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for JAZZ is $207.86, representing a +3.4% upside from the current price of $201.06. Price targets range from a low of $170.00 to a high of $235.00.
